Angelo Lombardo
0000-0001-8262-042X
Publication & Citation Trends
Publications
0 total
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease
Cited by 9
Semantic Scholar
Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I−/− iPSCs for β cell replacement OA
Cited by 25
Semantic Scholar
DNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes OA
Cited by 63
Semantic Scholar
In vitro selection of Engineered Transcriptional Repressors for targeted epigenetic silencing and initial evaluation of their specificity profile OA
Cited by 0
Semantic Scholar
Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency. OA
Cited by 23
Semantic Scholar
Deletion of a pseudogene within a fragile site triggers the oncogenic expression of the mitotic CCSER1 gene OA
Cited by 2
Semantic Scholar
Altered Cl− homeostasis hinders forebrain GABAergic interneuron migration in a mouse model of intellectual disability OA
Cited by 13
Semantic Scholar
Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Ex Vivo and In Vivo Genetic Engineering OA
Cited by 29
Semantic Scholar
Research Topics
CRISPR and Genetic Engineering
(45)
Virus-based gene therapy research
(37)
RNA Interference and Gene Delivery
(25)
CAR-T cell therapy research
(25)
Pluripotent Stem Cells Research
(14)
Affiliations
Forest Institute
Albert Einstein College of Medicine
Montefiore Medical Center
Vita-Salute San Raffaele University
Polytechnic University of Turin